David C. Hohn, MD, was named President Emeritus and Executive Director of Health Policy at Roswell Park Cancer Institute (RPCI) in April 2007 as part of a planned transition of leadership, after serving for 10 years as President and CEO.
As RPCI President Emeritus and Executive Director of Health Policy, Dr. Hohn continues his national leadership role in health policy issues, especially as they relate to cancer research and treatment and the training of the next generation of cancer specialists. He is active in New York State cancer control initiatives and in the National Comprehensive Cancer Network (NCCN) as well as serving as a senior advisor to the Institute’s 13th President & CEO, Dr. Donald Trump.
During his tenure as Institute President, Dr. Hohn was widely credited with re-establishing the Institute as a leader in the national cancer community. He provided leadership and vision to implement the Institute’s first strategic plan focused on making RPCI internationally and nationally competitive in cancer science; finalized legislation to create a new governance model for RPCI as a New York State Public Benefit Corporation; stabilized funding and increased sources of revenue; reorganized RPCI's senior leadership team, clinical departments and scientific programs; successfully recruited over 160 senior leadership faculty, top-tier clinicians and scientists; completed the $250 million renovation and rebuilding of the Institute campus and the construction of a $74 million Center for Genetics & Pharmacology; implemented an innovative managed care strategy which opened regional access to RPCI; implemented community partnerships which broaden quality of cancer services to residents of Western New York; and increased patient referrals.
As Principal Investigator of the National Cancer Institute Cancer’s Center Support Grant (CCSG), Dr. Hohn led the successful renewal of Roswell Park’s designation as a comprehensive cancer center – a designation that the Institute has held continuously since 1974.
Dr. Hohn served for three years as Chairman of the Board of Directors of the NCCN, an alliance of 21 of the world’s leading cancer centers. He currently is a member of a number of Western New York civic and professional boards including the Buffalo Niagara Medical Campus, Buffalo Niagara Partnership and the Buffalo Philharmonic Orchestra.
Dr. Hohn came to RPCI from the University of Texas MD Anderson Cancer Center where, as Vice President for Patient Care from 1993 to 1997, his responsibilities included oversight of all clinical departments, clinical research programs and the protocol office.